All the news Showing 10 of 43 articles from: NAFLDGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Emricasan misses study endpoint for improving portal hypertension in people with NASH Liz Highleyman / 24 April 2019 The experimental caspase inhibitor emricasan did not meet the statistical threshold for improvement of portal hypertension in people with non-alcoholic steatohepatitis (NASH), but it did appear to have some benefit for those at ... NAFLD a rising cause of liver disease in people with HIV Liz Highleyman / 23 April 2019 Now that hepatitis C can be successfully treated, non-alcoholic fatty liver disease (NAFLD) is becoming an increasingly important cause of serious liver problems and liver-related death among people living with HIV in the ... Hepatic Steatosis Highly Prevalent in Young Adults With Lifelong HIV Infectious Disease Advisor / 17 April 2019 Obeticholic acid improves liver fibrosis in people with NASH Liz Highleyman / 12 April 2019 Obeticholic acid (Ocaliva) led to a significant improvement in liver fibrosis related to non-alcoholic steatohepatitis (NASH), offering a potential future option for an increasingly common liver disease with no good current therapies, researchers ... Experts warn of fatty liver disease 'epidemic' in young people The Guardian / 12 April 2019 Second-generation thiazolidinedione, MSDC-0602K may significantly improve liver enzymes, fibrosis, and glycaemic markers with minimal adverse events, according to a Phase 2b study EASL / 12 April 2019 With NASH results, Intercept Pharma will seek approval for first-ever treatment for fatty liver condition STAT / 19 February 2019 Gilead’s Liver-Drug Setback Clouds $35 Billion Dream Bloomberg / 13 February 2019 Gilead rocked by phase 3 failure of selonsertib in NASH Fierce BioTech / 13 February 2019 Experimental therapy improves liver health in people with fatty liver disease Liz Highleyman / 31 January 2019 NGM282, an experimental fibroblast growth factor analogue, reduced liver fat build-up and the development of scar tissue in people with non-alcoholic steatohepatitis, according to studies presented at the recent AASLD Liver Meeting in ... ← First12345Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds